Finance

Lists
DHC:NASDAQ
Diversified Healthcare Trust
$7.98
-3.80%
(-0.32) 1D
Aug 18, 3:55:35 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DHC...
Open
$8.30
High
$8.36
Low
$8.02
Mkt. cap
1.95B
Avg. vol.
1.70M
Volume
731.88K
Dividend
0.50%
Quarterly dividend
$0.01
Ex-dividend date
Apr 21, 2026
52-wk high
$9.66
52-wk low
$3.38
EPS
-$1.11
Beta
2.31
Shares outstanding
242.13M
No. of employees
0
Open
$8.30
High
$8.36
Low
$8.02
Mkt. cap
1.95B
Avg. vol.
1.70M
Volume
731.88K
Dividend
0.50%
Quarterly dividend
$0.01
Ex-dividend date
Apr 21, 2026
52-wk high
$9.66
52-wk low
$3.38
EPS
-$1.11
Beta
2.31
Shares outstanding
242.13M
No. of employees
0
News stories
From web sources and news partners
About Diversified Healthcare Trust
CEO-
Employees0
Founded1998
HeadquartersNewton, Massachusetts, United States
SectorReal estate investment trust
Websitedhcreit.com
Analyst ratings
Based on 3 analysts giving stock ratings to DHC in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DHC in the last 3 months.
Highest
Current $7.98
$11.50 (+44.20%)
Average
$10.17 (+27.52%)
Lowest
$8.00 (+0.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Diana
Maxim Group
Buy
Reiterated
$11.50
+44.2%
08/05/2026
Michael Carroll
RBC Capital
Hold
Maintained
$8.00
+0.3%
06/18/2026
John Massocca
B. Riley Securities
Buy
Reiterated
$11.00
+37.9%
06/09/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.10 / -$0.16
+36.45%beat
Revenue / Est. (USD)
365.39M / 370.76M
-1.45%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
388.71M
379.57M
366.47M
365.39M
Cost of goods sold
326.54M
316.15M
294.25M
284.03M
Cost of revenue
326.54M
316.15M
294.25M
284.03M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.79M
12.54M
14.04M
19.33M
Operating expense
78.11M
74.54M
76.95M
81.88M
Total operating expenses
404.66M
390.69M
371.20M
365.90M
Operating income
-15.95M
-11.12M
-4.73M
-518.00K
Other non operating income
-774.00K
-
-
-
EBT including unusual items
-163.70M
-20.71M
-42.65M
-36.12M
EBT excluding unusual items
-60.53M
-29.33M
-41.45M
-35.49M
Income tax expense
337.00K
514.00K
622.00K
1.30M
Effective tax rate
-0.21%
-2.48%
-1.46%
-3.59%
Other operating expenses
-
-
-
-
Net income
-164.04M
-21.22M
-43.28M
-37.42M
Net profit margin
-42.20%
-5.59%
-11.81%
-10.24%
Earnings per share
-0.22
-0.06
-0.13
-0.10
Interest and investment income
-
1.53M
233.00K
258.00K
Interest expense
-48.89M
-46.86M
-37.04M
-37.08M
Net interest expenses
-48.89M
-45.32M
-36.81M
-36.82M
Depreciation and amortization charges
65.32M
62.01M
62.91M
62.54M
EBITDA
49.40M
50.92M
58.21M
62.05M
Gain or loss from assets sale
-1.26M
-13.76M
1.21M
629.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps